Key result
Adding AF type and renal dysfunction to CHA2DS2-VASc improves LAA thrombus prediction over standard scores.
Why the study?
The study aimed to identify predictors of LAA thrombus in AF patients and enhance the prognostic value of the CHA2DS2-VASc score.
Does the CHA2DS2-VASc-RAF score improve the prediction of left atrial appendage thrombus compared to the CHA2DS2-VASc score in patients with atrial fibrillation?
Cohort (n=1,353)
Yes
Does the CHA2DS2-VASc-RAF score improve the prediction of left atrial appendage thrombus compared to the CHA2DS2-VASc score in patients with atrial fibrillation?
Adding atrial fibrillation type and renal dysfunction to the CHA2DS2-VASc score significantly improves the prediction of left atrial appendage thrombus in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May refine LAA thrombus prediction in AF; leaves open need for prospective outcome validation before clinical adoption.
Objective We aimed to identify predictors of left atrial appendage (LAA) thrombus in patients with atrial fibrillation (AF) and to enhance the prognostic value of the CHA 2 DS 2 -VASc score. Methods Derivation cohort included 1033 consecutive AF patients referred for catheter ablation or direct current cardioversion, in whom transoesophageal echocardiography (TOE) was performed prior to the procedure. Logistic regression analysis was used to identify predictors of LAA thrombus on TOE. Receiver operating characteristic (ROC) curves were constructed to compare the newly developed score with the CHA 2 DS 2 and CHA 2 DS 2 -VASc scores in the derivation and the validation (n=320) cohort. Results On TOE, LAA thrombus was present in 59 (5.7%) patients in the derivation cohort. Aside from variables encompassed by the CHA 2 DS 2 -VASc score, LAA thrombus predictors included AF type (persistent/’permanent’ vs paroxysmal) and renal dysfunction. These predictors were incorporated into the CHA 2 DS 2 -VASc score. In ROC analysis, area under the curve (AUC) for the new score (CHA 2 DS 2 -VASc-RAF score) was significantly higher (0.81) than those for the CHA 2 DS 2 and CHA 2 DS 2 -VASc scores (0.71 and 0.70, respectively). In the validation cohort, the CHA 2 DS 2 -VASc-RAF score also performed significantly better (AUC of 0.88) than the CHA 2 DS 2 and CHA 2 DS 2 -VASc scores (AUC of 0.63 and 0.60, respectively). Conclusion In real-world AF patients with majority on oral anticoagulation, LAA thrombus was found in approximately 6%. Two variables not included in the CHA 2 DS 2 -VASc score (AF type and renal dysfunction) proved strong, independent predictors of LAA thrombus and might improve thromboembolic risk stratification.
No takes yet. Share an insight, caveat, or question.
Kapłon‐Cieślicka et al. (2019) conducted a cohort in Atrial fibrillation (n=1,353). CHA2DS2-VASc-RAF score (incorporating non-paroxysmal AF and renal dysfunction GFR <56 mL/min/1.73 m2) vs. CHA2DS2-VASc and CHADS2 scores (or paroxysmal AF and GFR ≥56 mL/min/1.73 m2) was evaluated on Presence of left atrial appendage thrombus on transoesophageal echocardiography (associated with renal dysfunction GFR <56 mL/min/1.73 m2 in the CHA2DS2-VASc multivariate model) (OR 2.41, 95% CI 1.33 to 4.37, p=0.004). Adding AF type and renal dysfunction to CHA2DS2-VASc (CHA2DS2-VASc-RAF) significantly improved LAA thrombus prediction in derivation (AUC 0.81 vs 0.70, p=0.0003) and validation (0.88 vs 0.60) cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: